Abstract
Glioblastomas epidemiology and aggressiveness demand for a well characterization of biochemical mechanisms of the cells. The discovery of oxidative tumours related to chemoresistance is changing the prevalent view of dysfunctional mitochondria in cancer cells. Thus, glioblastomas metabolism is now an area of intense research, wherein was documented a high heterogeneity in energy metabolism and in particular in mitochondrial OxPhos. We report results gained by investigating mitochondrial OxPhos and bioenergetics, in a model of three human glioblastoma cell lines characterized by a different PTEN gene status. Functional data are analysed in relation to the expression levels of some main transcription factors and signalling proteins, which can be involved in the regulation of mitochondrial biogenesis and activity. Collectively, our observations indicate for the three cell lines a similar bioenergetic phenotype maintaining a certain degree of mitochondrial oxidative activity, with some difference for PTEN-wild type SF767 cells respect to PTEN-deleted A172 and U87MG characterized by a loss-of-function point mutation of PTEN. SF767 has lower ATP content and higher ADP/ATP ratio, higher AMPK activating-phosphorylation evoking energy impairment, higher OxPhos complexes and PGC1α-Sirt3-p53 protein abundance, in line with a higher respiration. Finally, SF767 shows a similar mitochondrial energy supply, but higher non-phosphorylating respiration linked to dissipation of protonmotive force. Intriguingly, it is now widely accepted that a regulated mitochondrial proton leak attenuate ROS generation and in tumours may be at the base of pro-survival advantage and chemoresistance.
Similar content being viewed by others
Abbreviations
- ADP:
-
Adenosine 5′-diphosphate
- AMPK:
-
AMP-activated protein kinase
- ATP:
-
Adenosine 5′-trphosphate
- CS:
-
Citrate synthase
- 2-DG:
-
2-deoxyglucose
- DMEM:
-
Dulbecco’s modified Eagle’s medium
- ECAR:
-
Extracellular acidification rate
- EDTA:
-
Ethylenediaminetetraacetic acid
- ETS:
-
Electron transport system
- FCCP:
-
Carbonyl cyanide p-trifluoro-methoxyphenyl hydrazine
- HSP60:
-
Heat shock protein 60
- LKB1:
-
Liver kinase B1
- MDM2:
-
Mouse double minute 2
- mTOR:
-
Mammalian target of rapamycin
- mTORC1:
-
Mammalian target of rapamycin complex 1
- OCR:
-
Oxygen consumption rate
- OxPhos:
-
Oxidative phosphorylation
- PBS:
-
Phosphate–buffered saline
- PGC1α:
-
Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha
- PS:
-
Phosphorylating system
- PTEN:
-
Phosphatase and tensin homolog
- ROS:
-
Reactive oxygen species
- SDS-PAGE:
-
Sodium dodecyl sulphate - polyacrylamide gel electrophoresis
- Sirt3:
-
Silent mating-type information regulation 2 homolog sirtuin
- SCO2:
-
Cytochrome c oxidase assembly protein
- TCA:
-
Tricarboxylic acid
- TFAM:
-
Mitochondrial transcription factor A
- TIGAR:
-
TP53-induced glycolysis and apoptosis regulator
- TMPD:
-
Tetramethyl-p-phenylenediamine dihydrochloride
- TOM:
-
Translocase of outer mitochondrial membrane
- WHO:
-
World health organization
References
Antico Arciuch VG, Russo MA, Kang KS, Di Cristofano A (2013) Inhibition of AMPK and Krebs cycle gene expression drives metabolic remodeling of Pten-deficient preneoplastic thyroid cells. Cancer Res 73:5459–5472
Austin S, St-Pierre J (2012) PGC1α and mitochondrial metabolism--emerging concepts and relevance in ageing and neurodegenerative disorders. J Cell Sci 125:4963–4971
Azarias G, Perreten H, Lengacher S, Poburko D, Demaurex N, Magistretti J, Chatton J (2011) Glutamate transport decreases mitochondrial pH and modulates oxidative metabolism in astrocytes. J Neurosci 31:3550–3559
Azzu V, Brand MD (2010) The on-off switches of the mitochondrial uncoupling proteins. Trends Biochem 35:298–307
Bergeaud M, Mathieu L, Guillaume A, Moll UM, Mignotte B, Le Floch N, Vayssière JL, Rincheval V (2013) Mitochondrial p53 mediates a transcription-independent regulation of cell respiration and interacts with the mitochondrial F1F0-ATP synthase. Cell Cycle 12:2781–2793
Brandt AP, Pires Ado R, Rocha ME, Noleto GR, Acco A, de Souza CE, Echevarria A, Canuto AV, Cadena SM (2014) Sydnone SYD-1 affects the metabolic functions of isolated rat hepatocytes. Chem Biol Interact 218:107–114
Brenmoehl J, Hoeflich A (2013) Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. Mitochondrion 13:755–761
Chautard E, Ouedraogo ZG, Biau J, Verrelle P (2014) Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness. J Neuro-Oncol 117:205–215
Chen Y, LL F, Wen X, Wang XY, Liu J, Cheng Y, Huang J (2014) Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis 5:e1047. https://doi.org/10.1038/cddis.2014.14
Cheng J, Nanayakkara G, Shao Y, Cueto R, Wang L, Yang WY, Tian Y, Wang H, Yang X (2017) Mitochondrial proton leak plays a critical role in pathogenesis of cardiovascular diseases. Adv Exp Med Biol 982:359–370
Comelli M, Domenis R, Bisetto E, Contin M, Marchini M, Ortolani F, Tomasetig L, Mavelli I (2011) Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts. Mitochondrion 11:315–326
Cuezva JM, Ortega AD, Willers I, Sánchez-Cenizo L, Aldea M, Sánchez-Aragó M (2009) The tumor suppressor function of mitochondria: translation into the clinics. Biochim Biophys Acta 1792:1145–1158
Derdak Z, Mark NM, Beldi G, Robson SC, Wands JR, Baffy G (2008) The mitochondrial uncoupling protein-2 promotes chemoresistance in cancer cells. Cancer Res 68:2813–2819
Di Cristofano A, Pandolfi PP (2000) The multiple roles of PTEN in tumor suppression. Cell 100:387–390
Endersby R, Baker SJ (2008) PTEN signalling in brain: neuropathology and tumorigenesis. Oncogene 27:5416–5430
Feichtinger RG, Weis S, Johannes AM, Zimmermann F, Geilberger R, Sperl W, Kofler B (2014) Alterations of oxidative phosphorylation complexes in astrocytomas. Glia 62:514–525
Fox PT, Raichle ME, Mintun MA, Dence C (1988) Nonoxidative glucose consumption during focal physiologic neural activity. Science 241:462–464
Galeffi F, Turner DA (2012) Exploiting metabolic differences in glioma therapy. Curr Drug Discov Technol 9:280–293
George J, Ahmad N (2016) Mitochondrial sirtuins in cancer: emerging roles and therapeutic potential. Cancer Res 76:2500–2506
Giralt A, Villarroya F (2012) SIRT3, a pivotal actor in mitochondrial functions: metabolism, cell death and aging. Biochem J 444:1–10
Gnaiger E (2008) Polarographic oxygen sensors, the oxygraph and high-resolution respirometry to assess mitochondrial function. In: Dykens JA, Will Y (eds) Mitochondrial dysfunction in drug-induced toxicity. Wiley, Inc, Hoboken, pp 327–352
Griguer CE, Oliva CR, Gillespie GYJ (2005) Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neuro-Oncol 74:123–133
Hardie DG (2011) AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 25:1895–1908
Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H (2001) Cell cycle regulation via p53 phosphorylation by a 5′-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287:562–567
Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469–479
Kao TY, Chiu YC, Fang WC, Cheng CW, Kuo CY, Juan HF, Wu SH, Lee AY (2015) Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex. Cell Death Dis 6:e1642. https://doi.org/10.1038/cddis.2015.9
Keniry M, Parsons R (2008) The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27:5477–5485
Kim J, Han J, Jang Y, Kim SJ, Lee MJ, Ryu MJ, Kweon GR, Heo JY (2015) High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma. Int J Oncol 47:1009–1016
Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149:274–229
Liu M, Wang J, Qi Q, Huang B, Chen A, Li X, Wang J (2016) Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway. Oncol Rep. https://doi.org/10.3892/or.2016.4998
Lowry OH, Rosebrough NJ, Lewis RA, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Margareto J, Leis O, Larrarte E, Idoate MA, Carrasco A, Lafuente JV (2007) Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 32:53–63
Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, Rajagopalan KN, Maddie M, Vemireddy V, Zhao Z, Cai L, Good L, BP T, Hatanpaa KJ, Mickey BE, Matés JM, Pascual JM, Maher EA, Malloy CR, Bachoo RM (2012) Analyses of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab 15:827–837
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM (2006) p53 regulates mitochondrial respiration. Science 312:1650–1653
Mesti T, Ocvirk J (2016) Malignant gliomas: old and new systemic treatment approaches. Radiol Oncol 50:129–138
Obre E, Rossignol R (2015) Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy. Int J Biochem Cell Biol 59:167–181
O'Brien LC, Keeney PM, Bennett JP Jr (2015) Differentiation of human neural stem cells into motor neurons stimulates mitochondrial biogenesis and decreases glycolytic flux. Stem Cells Dev 24:1984–1994
Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445–1453
Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892–6899
Özcan E, Çakır T (2016) Reconstructed metabolic network models predict flux-level metabolic reprogramming in glioblastoma. Front Neurosci 10:156. https://doi.org/10.3389/fnins.2016.00156
Pesta D, Gnaiger E (2012) High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810:25–58
Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133–3144
Rodrigues-Silva E, Siqueira-Santos ES, Ruas JS, Ignarro RS, Figueira TR, Rogério F, Castilho RF (2017) Evaluation of mitochondrial respiratory function in highly glycolytic glioma cells reveals low ADP phosphorylation in relation to oxidative capacity. J Neuro-Oncol 133:519–529
Rosso P, Fioramonti M, Fracassi A, Marangoni M, Taglietti V, Siteni S, Segatto M (2016) AMPK in the central nervous system: physiological roles and pathological implications. Res Rep Biol 7:1–13
Sánchez-Aragó M, García-Bermúdez J, Martínez-Reyes I, Santacatterina F, Cuezva JM (2013) Degradation of IF1 controls energy metabolism during osteogenic differentiation of stem cells. EMBO Rep 14:638–644
Scarpulla RC (2002) Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim Biophys Acta 1576:1–14
Shackelford DB (2013) Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor. J Carcinog 12:16. https://doi.org/10.4103/1477-3163.116323
Shelly M, Cancedda L, Heilshorn S, Sumbre G, Poo MM (2007) LKB1/STRAD promotes axon initiation during neuronal polarization. Cell 129:565–577
Shlomi T, Benyamini T, Gottlieb E, Sharan E, Ruppin E (2011) Genome-scale metabolic modeling elucidates the role of proliferative adaptation in causing the Warburg effect. PLoS Comput Biol 7(3):e1002018
Strickland M, Stoll EA (2017) Metabolic Reprogramming in Glioma. Front Cell Dev Biol 5(43):1–32
Tang H, Li J, Liu X, Wang G, Luo M, Deng H (2016) Down-regulation of HSP60 suppresses the proliferation of glioblastoma cells via the ROS/AMPK/mTOR pathway. Sci Rep 6:28388. https://doi.org/10.1038/srep28388
Vassilev LT, BT V, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303:844–848
Wang F, Fu X, Chen X, Chen X, Zhao Y (2010) Mitochondrial uncoupling inhibits p53 mitochondrial translocation in TPA-challenged skin epidermal JB6 cells. PLoS One 5(10):e13459. https://doi.org/10.1371/journal.pone.0013459
Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallmann T, Carlson M, Carling D (2003) LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 13:2004–2008
Xie Z, Dong Y, Zhang M, Cui MZ, Cohen RA, Riek U, Neumann D, Schlattner U, Zou MH (2006) Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. J Biol Chem 281:6366–6375
Yeung KY, Dickinson A, Donoghue JF, Polekhina G, White SJ, Grammatopoulos DK, McKenzie M, Johns TG, St John JC (2014) The identification of mitochondrial DNA variants in glioblastoma multiforme. Acta Neuropathol Commun 2:1. https://doi.org/10.1186/2051-5960-2-1
Zhang Y, Zhou L (2012) Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation. Biochem Biophys Res Commun 423:26–31
Zong WX, Rabinowitz JD, White E (2016) Mitochondria and cancer. Mol Cell 61:667–676
Acknowledgements
The authors gratefully acknowledge doctor Pier Giorgio Mastroberardino, Department of Genetics Erasmus Medical Center Rotterdam, for the useful discussion of data, as well as prof. Claudio Brancolini and prof. Gianluca Tell, Department of Medicine, University of Udine for glioblastoma cell lines, and prof. Giovanna Lippe, Department of Agricultural, Food, Environmental and Animal Sciences, University of Udine, for TOM20 antibody. Additionally, Silvia Lolini and Luca Bazzichetto, Department of Medicine, University of Udine, for technical support.
Author information
Authors and Affiliations
Contributions
I.M. and M.C. designed research and interpreted results of experiments; M.C. and I.P. maintained cell lines and performed experiments of mitochondria imaging, cell respiration and bioenergetic phenotype; M.C. analysed data, prepared figures and drafted manuscript; I.P. and A.B. performed quantitative WB analyses; A.B. organised “Supplementary Content”; I.M. edited and revised manuscript.
Corresponding author
Electronic supplementary material
ESM 1
(DOCX 1353 kb)
Rights and permissions
About this article
Cite this article
Comelli, M., Pretis, I., Buso, A. et al. Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status. J Bioenerg Biomembr 50, 33–52 (2018). https://doi.org/10.1007/s10863-017-9737-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-017-9737-5